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ChaperoneLoss of DJ-1 function contributes to pathogenesis in Parkinson’s disease. Here, we investigate the
impact of aging and DJ-1 deﬁciency in transgenic mice. Ventral midbrain from young DJ-1-deﬁcient
mice revealed no change in 4-hydroxy-2-nonenal (4-HNE), but HSP60, HSP40 and striatal dopamine
turnover were signiﬁcantly elevated compared to wildtype. In aged mice, the chaperone response
observed in wildtype animals was absent from DJ-1-deﬁcient transgenics, and nigral 4-HNE immu-
noreactivity was enhanced. These changes were concomitant with increased striatal dopamine lev-
els and uptake. Thus, increased oxidants and diminished protein quality control may contribute to
nigral oxidative damage with aging in the model.
 2013 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
The link between DJ-1 and Parkinson’s disease (PD) was ﬁrst
established with the discovery of two homozygous mutations in
the DJ-1 gene in kindreds with autosomal recessive early-onset
parkinsonism [1]. Studies of the cellular role of DJ-1 have shown
pleomorphic function, which is oxidation dependent [2–4]. The
protein is involved in transcriptional and translational regulation
[3,5–8] as well as apoptosis and autophagy [9–15] and associates
with synaptic vesicles, mitochondria and nuclei [16–21]. DJ-1 has
also been implicated as a protease [22–26], although not all studies
support the idea of DJ-1-induced proteolysis [27,28]. An interesting
regulatory feature of DJ-1 involves its oxidative modiﬁcation. DJ-1,
in an oxidized form, exhibits chaperone activity and is able to pre-
vent the ﬁbrillation of the protein alpha-synuclein in vitro, an effect
not observed with reduced forms [2,4]. While these represent pos-
sible mechanisms by which DJ-1 may contribute to neurodegener-ation, most studies have focused on the sensitivity of DJ-1 to
oxidative challenge.
Models of DJ-1 deﬁciency have demonstrated increased suscep-
tibility to oxidative injury, providing evidence that DJ-1 is key in
the cellular response to stress [29–33]. After oxidative challenge,
DJ-1 undergoes an acidic pI shift which is: (i) transient, (ii) present
in human PD brain and (iii) due in part to the oxidation of a cys-
teine residue at position 106 (C106) [34,35]. The formation of sul-
ﬁnic acid at C106 via side chain oxidation correlates with the
elimination of hydrogen peroxide in vitro, indicating an anti-oxi-
dant function of the protein, and a redistribution of the protein
to the mitochondrial inner membrane [34,36–38]. Cell culture
and animal models of DJ-1-deﬁciency also demonstrate abnormal
mitochondrial membrane potential and morphology [11,17,39–
45].
Previous studies have utilized naïve aged (i.e. non-toxicant ex-
posed) DJ-1 knockout mice to evaluate the relationship between
DJ-1 and aging, with inconsistent outcomes. While striatal altera-
tions in dopamine content and protein carbonylation have been re-
ported with aging in null DJ-1 line [46], no evidence of oxidative
injury was observed in a distinct knockout mouse [47]. Conversely,
overexpression of DJ-1 has been shown to protect against toxicant-
induced injury within the nigrostriatal pathway and in cultured
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of reduced DJ-1 expression on striatal dopaminergic tone and
markers of nigrostriatal oxidative injury as a consequence of aging,
using DJ-1-deﬁcient mice [53].
2. Materials and methods
2.1. Animals
Mice were maintained on a 12-h light–dark cycle and given free
access to food and drinking water as well as standard environmen-
tal enrichment. All animal procedures and animal care methods
were approved by the Institutional Animal Care and Usage Com-
mittees for SRI International and The Parkinson’s Institute. Experi-
ments in this study were conducted and reported in accordance
with EU Directive 2010/63/EU for experimental animal use.
No protein was detected in brain from genotypic null mice as
previously described [31]. Male and female 3-4 month old litter-
mate mice from DJ-1-deﬁcient (n = 9–14) and DJ-1+/+ control
(n = 9–12) cohorts, along with DJ-1-deﬁcient and wildtype litter-
mate mice aged 15–18 months (n = 6–9 per genotype), were eutha-
nized by cervical dislocation. Brain regions were dissected on ice
and utilized for biochemical and histological analyses. Experiments
were performed by investigators blinded to group.
2.2. Neurochemistry
Striatal samples were dissected at the level of the anterior com-
missure. Samples were placed in 1 ml ice-cold 0.4 M perchloric
acid, sonicated and centrifuged [53]. The supernatant was collected
for measurement of dopamine (DA) and its metabolites, dihy-
droxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) by
reverse phase HPLC with electrochemical detection (Coulochem II
detector; ESA, Chelmsford, MA) [54]. Total protein was determined
using the Lowry method.
2.3. 3H-dopamine uptake
Striatal synaptosomes were prepared from fresh tissue homog-
enized in 0.3 M sucrose and incubated in assay buffer with [3H]-DA
(20 nM; PerkinElmer) as described [53]. Synaptosomes were incu-
bated for 10 min at 37 C, and then uptake was terminated by the
addition of ice-cold buffer and rapid vacuum ﬁltration. Filters were
washed, air-dried and placed in Econoscint (Fisher Scientiﬁc, Pitts-
burgh, PA) for scintillation counting. Uptake rate was calculated as
total-non-speciﬁc uptake, with non-speciﬁc uptake determined
with 10 lM nomifensine. Protein concentration was measured by
the Lowry method.
2.4. Immunohistochemistry
The mid- and hind-brain were post-ﬁxed in 4% paraformalde-
hyde in PBS. Brain blocks were subsequently cryoprotected in
10% and 30% sucrose for at least 4 h or until sunk and subsequently
frozen and maintained at 80 C. Coronal sections (40 lm) were
cut and collected serially into tubes containing cryoprotectant
solution and stored at 20 C until further use. Immunolabeling
with primary antibodies against rabbit or sheep tyrosine hydroxy-
lase ((TH);1:600, Pel Freez Biologicals) and/or rabbit 4-HNE
(1:2000, Calbiochem) was performed overnight at 4 C. For proﬁle
counting, sections were incubated successively in rabbit anti-4-
HNE, biotinylated anti-rabbit secondary antibody, and HRP-linked
avidin:biotin complex. Reactivity was visualized with DAB (Vector
Labs), and sections were then lightly counterstained with 0.5% Cre-
syl violet. Sections containing third nerve were used for analyses,as well as the sections 240 lm rostral and caudal to that section.
Counting was performed by two investigators blinded to age and
genotype. The substantia nigra was delineated at low magniﬁca-
tion and sampled at high magniﬁcation using the optical fraction-
ator technique [55]. For confocal microscopy, sections were
incubated with sheep anti-TH and rabbit anti-4-HNE primary anti-
bodies followed by FITC-conjugated goat anti-rabbit and Cy3-con-
jugated goat anti-sheep secondary antibodies, mounted in
Vectashield and coverslipped.
2.5. Stereological analysis
Serial coronal sections of mouse midbrain containing the entire
extent of the substantia nigra were cut on a cryostat at 40 lm, col-
lected in cryopreservative and stored. For stereological cell counts,
every 6th tissue section, encompassing the entire substantia nigra,
was probed for TH immunoreactivity and visualized with DAB as
described above. After sections were mounted to slides and air-
dried overnight, tissues were cleared, counterstained in 0.5% Cresyl
violet for 5 min, dehydrated and coverslipped in DePeX.
Stereological analysis was performed using an Olympus BH2
microscope with a motorized X-Y stage linked to a computer-as-
sisted stereological system (Castgrid; Olympus, Albertslund, Den-
mark). The substantia nigra pars compacta was delineated at low
magniﬁcation; the pars compacta subregion was distinguished
from pars reticulata based on cell morphology, cytoarchitecture
and orientation according to previous studies [53,56]. Sections
were systematically sampled at 100 magniﬁcation. They were
examined in the z direction through the optical plane with the dis-
sector at 8 lm and a guard range of 2 lm. The total number of
dopaminergic neurons was estimated using the optical fractionator
technique for an unbiased estimate of total number independent of
size, shape and shrinkage.
2.6. Immunoblotting
Following sonication of striatum in Tris–EDTA buffer with pro-
tease and phosphatase inhibitors (Sigma), samples were centri-
fuged, and the supernatant aspirated. Protein concentration was
measured by BCA assay (Pierce), and supernatant proteins sepa-
rated by SDS–PAGE (12% Tris–glycine, Invitrogen/Life Technolo-
gies, Carlsbad, CA) then transferred to nitrocellulose. Blots were
blocked in 5% milk and incubated overnight with chicken anti-
glyceraldehyde 3-phosphate dehydrogenase (1:2000, GAPDH;
Chemicon/Millipore, Billerica, MA), mouse anti-HSP40 (1:1000, As-
say Designs/Stressgen, Enzo Life Sciences, Farmingdale, NY), mouse
anti-HSP60 (1:1000, Assay Designs/Stressgen), and mouse anti-
HSP70 (1:800, Assay Designs/Stressgen). Next, appropriate peroxi-
dase-conjugated secondary antibodies were applied, and signal
visualized following incubation with chemiluminescent substrate
(Thermo Fisher Scientiﬁc, Rockford, IL). After exposure to CL-XPo-
sure Film (Thermo Scientiﬁc), immunoreactivity was quantiﬁed
by Image J software.
2.7. Statistical analyses
Differences among means were analyzed using two-way analy-
sis of variance (ANOVA) when comparing differences between
genotype and age. Bonferroni’s post hoc analysis was employed
when differences were observed in ANOVA testing (P 6 0.05).
3. Results
We evaluated whether changes in nigrostriatal dopaminergic
tone and oxidative stress occur as a consequence of aging in a
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young and old based on age (i.e. 3–4 or 15–18 months, respec-
tively) and by genotype (i.e. DJ-1-deﬁcient or wildtype
littermate).
Our laboratory and others have demonstrated functional alter-
ations in dopaminergic transmission in DJ-1-deﬁcient mice that
correlate with deﬁcits in motor behavior, and these are exacer-
bated with aging [53,57]. One mechanism thought to contribute
to these changes speciﬁcally involves an increase in DA transporter
reuptake activity; no signiﬁcant alterations in total DA or the
metabolites dihydroxyphenylacetic acid (DOPAC) and homovanil-
lic acid (HVA) levels have been reported in striatal homogenates
from young genotypic null mice and wildtype littermates
[30,31,33,46,58]. In the present study, we conﬁrmed no differences
due to genotype in DA, DOPAC and HVA levels in young mice
(Fig. 1A), however, further analyses revealed a modest, but signif-
icant, increase in DA turnover (21.8%) was noted in the 3–4 month-
old DJ-1-deﬁcient vs. wildtype littermates (Fig. 1C). Animals aged
to 15–18 months demonstrated DA levels signiﬁcantly higher
(47.6%) in the aged DJ-1-deﬁcient group (Fig. 1B), but DOPAC and
HVA were not altered as a consequence of genotype (Fig. 1B). Con-
sequently, DA turnover was signiﬁcantly decreased in aged ani-
mals lacking DJ-1 (Fig. 1C), along with increased DA uptake in
striatal synaptosomes vs. wildtype mice (Fig. 1D).Fig. 1. Neurochemical analyses of striatal DA and metabolites by HPLC in young and aged
DJ-1-deﬁcient (black bars) was used to measure DA, DOPAC and HVA by HPLC. (B) DA and
(C) DA turnover was calculated as a percentage of total metabolites (HVA + DOPAC) over
deﬁcient and WT mice (⁄; P < 0.01). (D) 3H-DA uptake was measured in synaptosomes f
shown as mean ± S.E.M.Since enhanced activity of the DA transporter and increases in
DA turnover can lead to increased intracellular oxidative stress
and mitochondrial dysfunction, we evaluated markers of oxidative
injury in the substantia nigra. A reactive aldehyde by-product of li-
pid peroxidation, 4-HNE, was evaluated using histological assess-
ment as previously described [59]. In young mice, little 4-HNE
immunoreactivity was apparent within nigral neurons regardless
of genotype (Fig. 2A). To assess a mitochondrial response indicative
of oxidative stress, levels of the mitochondrial chaperone HSP60
and HSP40 were evaluated; both proteins were signiﬁcantly aug-
mented, 49.3% and 39.8%, respectively, in ventral mesencephalon
homogenates from DJ-1-deﬁcient transgenics over wildtype litter-
mates (Fig. 2B, C). No difference due to genotype was noted in the
cytoplasmic chaperone HSP70 in young mice, however (Fig. 2G). In
the aged cohort, a robust increase in 4-HNE immunoreactivity was
apparent in substantia nigra of DJ-1-deﬁcient vs. wildtype mice
(Fig. 2D). While no difference between genotypes was observed
in HSP60 and HSP40 levels in ventral mesencephalon (Fig. 2E, F),
a marked depletion in HSP70 was noted in the aged animals lack-
ing DJ-1 (Fig. 2H).
To gain insight into whether the lack of difference in chaperone
expression in aged ventral midbrain was due to a signiﬁcant
change in the wildtype littermates or a decline in expression with
DJ-1 deﬁciency, we compared chaperone expression in young vs.DJ-1-deﬁcient vs. WTmice. (A) Striatal supernatant from youngWT (open bars) and
metabolites measurements were performed in striatum from agedmice (⁄; P < 0.05).
total DA measured and compared in young (left panel) and aged (right panel) DJ-1-
rom aged WT (open bar) and DJ-1-deﬁcient (black bar) mice; (⁄;P < 0.05). Data are
Fig. 2. Effect of genotype on lipid peroxidation and chaperone levels in young and aged DJ-1-deﬁcient vs. WT mice. (A) Coronal midbrain sections containing substantia nigra
were immunostained for the lipid peroxidation product 4-HNE in young WT and DJ-1-deﬁcient mice. ⁄ denotes third nerve. (B) Western blot analyses were used to assess
HSP60 and HSP40 in ventral mesencephalon from young mice. (C) Optical density of immunoreactivity was measured in Western blots from young WT (open bars) vs. DJ-1-
deﬁcient (black bars) mice (⁄, P < 0.05; ⁄⁄, P < 0.01). (D) Coronal midbrain sections containing substantia nigra were immunostained for 4-HNE in aged WT and DJ-1-deﬁcient
mice. ⁄ denotes third nerve. (E) Western blot analyses were used to assess HSP60 and HSP40 in ventral mesencephalon from aged mice. (F) Optical density of
immunoreactivity was measured in Western blots from aged WT (open bars) vs. DJ-1-deﬁcient (black bars) mice. (G) Optical density of HSP70 immunoreactivity was
measured in Western blots from ventral mesencephalon of young WT (open bar) vs. DJ-1-deﬁcient (black bar) mice. (H) Optical density of HSP70 immunoreactivity was
measured in Western blots from ventral mesencephalon of aged WT (open bar) vs. DJ-1-deﬁcient (black bar) mice. (⁄, P < 0.05). Bars = 40ln. Data are shown as mean ± S.E.M.
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expression were markedly increased with age in wildtype ventral
mesencephalon whereas this effect was absent in the aged
DJ-1-deﬁcient mice (Fig. 3A, C). Conversely, HSP40 expression
was unchanged in the samples from wildtype mice with aging,
but was signiﬁcantly decreased in the aged DJ-1-deﬁcient tissue
(Fig. 3B).
To verify that the oxidative damage was speciﬁc for the dopa-
minergic cell population, we performed dual label immunohisto-
chemistry using anti-TH and anti-4-HNE. Examination using
confocal microscopy in midbrain sections from naı¨ve DJ-1-deﬁ-
cient and wildtype littermate mice revealed that immunoreactivity
for 4-HNE co-localized with the TH-positive neuronal population
(Fig. 4A), providing evidence for lipid peroxidation within nigral
dopaminergic cells. In order to quantitatively assess any differ-
ences, we performed proﬁle counting of 4-HNE-positive cells in
the substantia nigra pars compacta following previously reportedFig. 3. Effect of aging on the mitochondrial and cytosolic chaperones in ventral mesence
the effects of aging on HSP60 (A), HSP40 (B) and HSP70 (C) levels in ventral mesencephalo
DJ-1-deﬁcient (right panel) genotypes. (⁄, P < 0.05). Data are shown as mean ± S.E.M.criteria [60]. In line with qualitative analyses (Fig. 2A), relatively
few 4-HNE-positive proﬁles per section were detected in young
mice with no difference between cohorts separated for genotype
(Fig. 4B). An increase in 4-HNE-positive neuronal proﬁles per sec-
tion was observed in aged vs. young wildtype substantia nigra
(Fig. 4B). Interestingly, this effect was exacerbated in nigral neu-
rons from aged DJ-1-deﬁcient mice. Signiﬁcantly higher numbers
of 4-HNE-immunoreactive proﬁles were detected in this cohort
compared to aged wildtype littermates (21.8 ± 3.1 vs. 9.7 ± 3.7),
revealing a 2.2-fold increase in this marker of oxidative injury. Be-
cause protein carbonylation has been reported in extra nigral re-
gions in PD brain [61], we evaluated if changes in 4-HNE were
apparent in the ventral tegmental area. No increase in 4-HNE reac-
tivity due to genotype was noted in this region from aged animals
(Fig. 4C). Lastly, we assessed whether increased nigral lipid perox-
idation in aged DJ-1-deﬁcient mice was associated with frank cell
death using unbiased stereological cell counting. No signiﬁcantphalon from DJ-1-deﬁcient and WT mice. Western blot analyses were used to assess
n from in young (open bars) vs. aged (black bars) mice from bothWT (left panel) and
Fig. 4. Lipid peroxidation in ventral midbrain and unbiased stereological cell counting of nigral dopaminergic neurons in DJ-1-deﬁcient vs. WT mice. (A) Dual-label
immunohistochemistry for 4-HNE (FITC) and TH (Cy3) was performed in sections in the substantia nigra from aged DJ-1-deﬁcient vs. WT mice. Merged panel (right)
demonstrates colocalization of immunoreactivities. (B) Quantitative assessment of lipid peroxidation by 4-HNE-positive neuronal proﬁles in substantia nigra from young and
aged DJ-1-deﬁcient and WT mice was performed. (⁄ aged vs. young WT, P < 0.05;⁄⁄ aged DJ-1 vs. young DJ-1, P < 0.01;  aged DJ-1 vs. aged WT; P < 0.05). (C) Coronal midbrain
sections containing the ventral tegmental area were immunostained for the lipid peroxidation product 4-HNE in aged WT and DJ-1-deﬁcient mice. ⁄ denotes third nerve.
Arrowhead denotes interpeduncular nucleus. (D) Unbiased stereological cell counting of Nissl-positive neurons in the substantia nigra was performed in aged DJ-1-deﬁcient
(black bar) vs. WT (open bar) mice. Bars = 50lm. Data are shown as mean ± S.E.M.
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rons in the substantia nigra was observed in aged animals (Fig. 4D).
4. Discussion
We evaluated young and aged cohorts from a line of DJ-1-deﬁ-
cient vs. wildtype littermates to gain insight into DJ-1-related
mechanisms that contribute to nigrostriatal vulnerability [31]. As
anticipated, striatal DA and its metabolites did not change signiﬁ-
cantly in young DJ-1-deﬁcient mice (Fig. 1A), with very few 4-HNE-
immunoreactive proﬁles observed in nigral neurons (Figs. 2A and
4B). However, a signiﬁcant increase in striatal DA turnover was
noted in young mice lacking DJ-1 vs. wildtype controls (Fig. 1C)
and was concomitant with marked elevations of the chaperonesHSP60 and HSP40, but not HSP70, in the ventral mesencephalon
(Fig. 2B). These ﬁndings demonstrate that, in the absence of sufﬁ-
cient DJ-1 in young mice, alterations in striatal DA turnover occur,
and these changes are accompanied by evidence for mitochondrial
stress, but not overt injury such as lipid peroxidation.
In aged DJ-1-deﬁcient vs. control mice, a distinct picture
emerges implying aberrant age-related responses in the nigrostri-
atal pathway of animals lacking DJ-1. Enhanced striatal DA but un-
changed DOPAC and HVA values were detected (Fig. 1B) resulting
in reduced DA turnover in the transgenics (Fig. 1C). Furthermore,
DA uptake was signiﬁcantly elevated in the DJ-1-deﬁcient mice
(Fig. 1D). Together, these ﬁndings suggest that with aging: (i)
abnormalities in striatal dopaminergic neurotransmission due to
insufﬁcient DJ-1 persist, and (ii) DJ-1 contributes to presynaptic
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lation of striatal DA levels.
The ﬁndings reported here provide insight into DJ-1-related
processes that may contribute to nigrostriatal injury with aging
(i.e. enhanced levels of reactive DA metabolites and toxic by-prod-
ucts). Although our laboratory and others found no difference in
total striatal DA levels due to genotype in young DJ-1-deﬁcient
mice (Fig. 1A) [53,57,58,62,63], the signiﬁcant increase in DA turn-
over shown here (Fig. 1C) suggests a condition that favors in-
creased generation of reactive oxygen species (ROS) in young
animals [64,65]. The precise pathway(s) underlying altered turn-
over due to DJ-1 insufﬁciency is currently not known. Previous
studies have shown that DJ-1 impacts TH transcription [66–68],
and, in two knockout lines on the highly oxidative stress-sensitive
C57BL/6 background, lack of DJ-1 leads to a reduced number of ni-
gral neurons with TH phenotype [63,69]. However, these reports
did not extend to enzymes involved in DA catabolism. Others have
reported that parkin diminishes monoamine oxidase (MAO) tran-
script levels and thus can limit oxidative stress through control
over MAO-mediated ROS production [70,71]. Given DJ-1-mediated
effects on transcription and translation [72], and reports of func-
tional interactions between DJ-1 and parkin [15,73], the possibility
of DJ-1-related modulation of DA catabolic enzymes exists, and
this warrants investigation in future studies.
Given that our lab and others have previously shown enhanced
DA transporter activity in DJ-1-deﬁcient young mice [53,58], in-
creased DA turnover is not entirely surprising. Though the eleva-
tion in DA turnover in young DJ-1-deﬁcient animals was modest
(21.8%), a substantial increase in two molecular chaperones,
HSP60 and HSP40, was concomitantly detected in the ventral mid-
brain from transgenics (Fig. 2B). HSP60 is a mitochondrial matrix
protein that serves as a chaperone to mitigate aberrant folding
[74]. Its expression has been shown to increase under conditions
of oxidative challenge [75,76], including those that enhance DA
catabolism [76], but can diminish in pathological states [77–79].
Similarly, HSP40 is also involved in the response to stress-induced
protein misfolding [80–82], acts as a co-chaperone with HSP70
[83], and is up-regulated following exposure to oxidative toxicants
that increase DA turnover [82] and consequently intracellular
hydrogen peroxide [64,84]. Therefore, it is possible that the ob-
served increases in nigral HSP expression in young mice are, at
least in part, in response to elevated turnover of DA in the striatum.
Importantly, these chaperones may serve as early indicators of
mitochondrial dysfunction that leads to nigral injury.
Interestingly, HSP70, a cytoplasmic chaperone, were not altered
due to genotype in ventral mesencephalon from young animals
(Fig. 2G). One possibility is that elevated levels of the co-chaperone
HSP40 are sufﬁcient to increase HSP70 ATPase activity and chaper-
one function [83]. Furthermore, although oxidative challenge from
increased DA turnover was present in young transgenics, there was
a lack of detectable 4-HNE (Fig. 2A). This lipid peroxidation product
can promote induction of HSP70 expression by a transcription fac-
tor heat shock factor 1 (HSF 1)-dependent mechanism. Under nor-
mal conditions, HSF 1 binds with HSP70, an interaction which
maintains HSF 1 in the cytoplasm. However, with oxidative injury,
4-HNE disrupts this protein-protein interaction allowing HSF 1 to
translocate into the nucleus, promoting transcription of the gene
encoding for HSP70 [85]. It may be that in the young transgenics,
as in other models [86], mitochondrial dysfunction is present and
occurs prior to cytoplasmic changes that elicit an HSP70 response
such as cytoplasmic protein misfolding.
Increased striatal DA values in aged DJ-1-deﬁcient mice are con-
sistent with ﬁndings of Chen et al. (2005); this, in combination
with an age-related decline in HVA (Fig. 1B), caused a signiﬁcant
reduction in DA turnover in DJ-1-deﬁcient striatum (Fig. 1C). Given
that DJ-1 acts as a transcriptional activator for TH [67,68], the ﬁnd-ing of increased striatal DA with aging seems somewhat counterin-
tuitive. It is likely that the enhanced DA transporter activity
observed in older DJ-1-deﬁcient mice contributes to this effect
(Fig. 1D), as increased reuptake of DA would be anticipated to in-
crease neurotransmitter levels within the tissue [57]. By example,
in DA transporter-knockout mice, reuptake is attenuated, and total
tissue levels of DA are reduced in the striatum [87]. Another plau-
sible explanation is that the activities of DA metabolic enzymes,
including TH, aromatic amino acid decarboxylase [88,89] and cat-
echol-O-methyltransferase [90] may be affected by oxidative chal-
lenge. In response to the herbicide paraquat or the dopaminergic
toxin 6-hydroxydopamine, for example, striatal TH activity in ro-
dents is upregulated [91–93]. Further, recent studies have shown
that the lack of DJ-1enhances the activity of extracellular signal-re-
lated kinase (ERK) [94], which can phosphorylate TH; it is possible
that DJ-1-related elevation in ERK activity may promote increased
TH modiﬁcation and consequently activity in DJ-1-deﬁcient
striatum.
It is important to point out that the enhanced striatal DA uptake
in the aged DJ-1-deﬁcient mice (Fig. 1D), in combination with in-
creased DA levels, may promote more robust 4-HNE staining and
proﬁle counts observed in nigral neurons from the transgenics vs.
wildtype mice (Fig. 4B). Recent work by Lev and colleagues re-
vealed that DJ-1 regulates expression of the vesicular monoamine
transporter-2 (VMAT2) which removes reactive DA from the cyto-
plasm and sequesters the neurotransmitter in synaptic vesicles
[95]. Thus, it is possible that VMAT2 deﬁciency in the absence of
DJ-1 may also contribute to lipid peroxidation through increased
levels of cytoplasmic DA. Our detection of nigral dopaminergic 4-
HNE deposition is divergent from an earlier study which did not
detect frank oxidative damage with aging in a distinct DJ-1 knock-
out line [96]. Subsequent work from this group, however, con-
ﬁrmed elevated ROS production with DJ-1 deﬁciency [42]. These
ﬁndings, along with the results presented here, are consistent with
the idea that insufﬁcient DJ-1 leads to impairments in mitochon-
drial uncoupling proteins that respond to oxidative challenge
[42,97]. Although cells were damaged, there was no signiﬁcant ni-
gral dopaminergic cell death (Fig. 4D). Thus, these neurons may
have a ‘silent lesion’ and are likely more vulnerable to subsequent
insult (i.e. risk factors for sporadic PD).
Age-related increases in the chaperones HSP60 and HSP70 ob-
served in wildtype mice were absent from the DJ-deﬁcient mice
(Fig. 3A, C). Enhanced HSP60 and HSP70 in mammalian brain have
been reported with senescence [98]; however, the diminished
HSP60 levels in the aged transgenics mimics an effect noted previ-
ously in disease states and models involving mitochondrial dys-
function (Fig. 3A) [77–79]. Our data further implicate a
modulatory role for DJ-1 in HSP-mediated protein quality control.
Reduced HSP levels may be due to chronic inhibition of the Nrf2
transcription factor response caused by DJ-1 deﬁciency. Normally,
DJ-1 binds to Nrf2 and prevents its interaction with Keap1.
Keap1–Nrf2 binding signals ubiquitination of Nrf2 resulting in its
degradation through the proteasome and reducing expression of
anti-oxidant molecules and HSPs including HSP40 and HSP70
[52]. Indeed, the lack of an Nrf2-mediated response has been
observed in another model of DJ-1 insufﬁciency and contributes
to deﬁcits in protein quality control [99].
While decreases in proteasomal subunits have been reported in
another DJ-1 knockout mouse [100], this is the ﬁrst study to dem-
onstrate that the lack of DJ-1 attenuates age-induced HSP expres-
sion. Mitochondrial and cytoplasmic proteins in nigral neurons
from aged DJ-1-deﬁcient mice, thus, are likely more susceptible
to lipid peroxidation and aberrant protein folding. Taken together,
the ﬁndings support the idea that changes in DJ-1 levels and func-
tion(s), due to either genetic variation in familial parkinsonism or
irreversible oxidation of DJ-1 observed in the sporadic disease
A.V. Raman et al. / FEBS Letters 587 (2013) 1562–1570 1569[101], render neurons more vulnerable to protein handling abnor-
malities, oxidative damage, and ultimately nigrostriatal lesioning.
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